Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03915717 · ClinicalTrials.gov registry record
Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring
A clinical trial, sponsored by Sonavex.
- Terminated
- Registry status
- 14
- Enrollment target
NCT03915717 is a clinical trial that was terminated before completion, run by Sonavex. The registered enrollment target is 14 participants.
The verdict
NCT03915717 was terminated before completion, sponsored by Sonavex.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the performance of the EchoMark and EchoSure as an ultrasound-based method of monitoring the viability of free flaps and patency of at-risk vessels.
Interventions
- DEVICE EchoMark
- DEVICE EchoSure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-09-19 |
| Est. Completion | 2022-05-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03915717
The ClinicalTrials.gov registry entry for NCT03915717 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sonavex, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EchoMark is the first listed.
NCT03915717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03915717 about?
NCT03915717 is a clinical study titled "Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring". The purpose of this study is to evaluate the performance of the EchoMark and EchoSure as an ultrasound-based method of monitoring the viability of free flaps and patency of at-risk vessels.
What is the current status of trial NCT03915717?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2019-09-19. Estimated completion is 2022-05-05.
What interventions are being tested in trial NCT03915717?
The interventions under investigation include: EchoMark (DEVICE), EchoSure (DEVICE).
Who is sponsoring clinical trial NCT03915717?
This trial is sponsored by Sonavex, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.